These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 1881582)

  • 1. Anti-rejection therapy in renal transplantation: Use of the monoclonal antibody OKT3.
    Nicholson ML; Donnelly PK; Veitch PS; Bell PR
    Nephrol Dial Transplant; 1991; 6(4):275-9. PubMed ID: 1881582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoclonal antibody OKT3 therapy in pediatric kidney transplant recipients.
    Leone MR; Barry JM; Alexander SR; Melvin T; Striegel J; Reller K; Henell KR; Kimball J; Funnell MB; Goldstein G
    J Pediatr; 1990 May; 116(5):S86-91. PubMed ID: 2139465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of a brief steroid trial before initiating OKT3 therapy for renal allograft rejection.
    Thistlethwaite JR; Stuart JK; Mayes JT; Gaber AO; Stuart FP
    Am J Kidney Dis; 1988 Feb; 11(2):94-8. PubMed ID: 3277413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized clinical trial of OKT3 monoclonal antibody for acute rejection of cadaveric renal transplants.
    Ortho Multicenter Transplant Study Group
    N Engl J Med; 1985 Aug; 313(6):337-42. PubMed ID: 2861567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monoclonal antibody (OKT3) rescue in refractory acute renal allograft rejection: report of 3 cases.
    Suvanapha R; Laorpatanaskul S; Vajaraphongse R; Kitisin P; Srivatanawongsa V; Mulikamas S; Vajaraphongse K; Boonvisut S; Chusil S; Panmuong W
    J Med Assoc Thai; 1989 Dec; 72(12):708-13. PubMed ID: 2628539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Half dose of OKT3 is efficient in treatment of steroid-resistant renal allograft rejection.
    Midtvedt K; Tafjord AB; Hartmann A; Eide TC; Holdaas H; Nordal KP; Draganov B; Sødal G; Leivestad T; Fauchald P
    Transplantation; 1996 Jul; 62(1):38-42. PubMed ID: 8693541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concomitant low-dose cyclosporine and OKT3 therapy for renal transplant rejection.
    Hricik DE; Zarconi J; Schulak JA
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1755-7. PubMed ID: 2652574
    [No Abstract]   [Full Text] [Related]  

  • 8. OKT3 treatment of steroid-resistant renal allograft rejection.
    Thistlethwaite JR; Gaber AO; Haag BW; Aronson AJ; Broelsch CE; Stuart JK; Stuart FP
    Transplantation; 1987 Feb; 43(2):176-84. PubMed ID: 3544373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved results using OKT3 as induction immunosuppression in renal allograft recipients with delayed graft function.
    Benvenisty AI; Cohen D; Stegall MD; Hardy MA
    Transplantation; 1990 Feb; 49(2):321-7. PubMed ID: 2137654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The reuse of OKT3 after previous rejection or induction therapy in cadaveric renal transplantation.
    Shield CF; Hughes JD
    Am J Kidney Dis; 1989 Nov; 14(5 Suppl 2):35-8. PubMed ID: 2510509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. OKT3 prophylaxis versus conventional drug therapy: single-center perspective, part of a multicenter trial.
    Kahana L; Narvarte J; Ackermann J; LeFor W; Weinstein S; Wright C; deQuesada A; Baxter J; Shires D
    Am J Kidney Dis; 1989 Nov; 14(5 Suppl 2):5-9. PubMed ID: 2510510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of a second course of OKT3 monoclonal anti-T cell antibody for treatment of renal allograft rejection.
    Norman DJ; Shield CF; Henell KR; Kimball J; Barry JM; Bennett WM; Leone M
    Transplantation; 1988 Oct; 46(4):523-9. PubMed ID: 3140448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of OKT3 monoclonal antibody and corticosteroids in the treatment of acute renal allograft rejection.
    Deierhoi MH; Barber WH; Curtis JJ; Julian BA; Luke RG; Hudson S; Barger BO; Diethelm AG
    Am J Kidney Dis; 1988 Feb; 11(2):86-9. PubMed ID: 3277412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of low-dose cyclosporine on the outcome of treatment with OKT3 for acute renal allograft rejection.
    Hricik DE; Zarconi J; Schulak JA
    Transplantation; 1989 Feb; 47(2):272-7. PubMed ID: 2493175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. OKT3 for the treatment of steroid-resistant acute renal allograft rejection.
    Jogose JT; Bailey RR; Lynn KL; Robson RA; Wells JE
    Nephron; 1997; 77(3):298-303. PubMed ID: 9375823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A prospective comparison of murine monoclonal CD-3 (OKT3) antibody-based and equine antithymocyte globulin-based rejection prophylaxis in cardiac transplantation. Decreased rejection and less corticosteroid use with OKT3.
    Renlund DG; O'Connell JB; Gilbert EM; Hammond ME; Burton NA; Jones KW; Karwande SV; Doty DB; Menlove RL; Herrick CM
    Transplantation; 1989 Apr; 47(4):599-605. PubMed ID: 2523099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The long-term effects of prophylactic OKT3 monoclonal antibody in cadaver kidney transplantation--a single-center, prospective, randomized study.
    Abramowicz D; Goldman M; De Pauw L; Vanherweghem JL; Kinnaert P; Vereerstraeten P
    Transplantation; 1992 Sep; 54(3):433-7. PubMed ID: 1412723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The high failure rate of OKT3 in the treatment of acute renal allograft rejection resistant to steroids with or without antithymocyte globulin.
    Davies SP; Brown EA; Woodrow DF; Phillips ME; Gower PE; Mee AD
    Transplantation; 1991 Oct; 52(4):746-9. PubMed ID: 1926361
    [No Abstract]   [Full Text] [Related]  

  • 19. 15-Deoxyspergualin "rescue therapy" for methylprednisolone-resistant rejection of renal transplants as compared with anti-T cell monoclonal antibody (OKT3).
    Okubo M; Tamura K; Kamata K; Tsukamoto Y; Nakayama Y; Osakabe T; Sato K; Go M; Kumano K; Endo T
    Transplantation; 1993 Mar; 55(3):505-8. PubMed ID: 8456469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunologic monitoring with Orthoclone OKT3 therapy.
    Schroeder TJ; First MR; Hurtubise PE; Marmer DJ; Martin DM; Mansour ME; Melvin DB
    J Heart Transplant; 1989; 8(5):371-80. PubMed ID: 2529358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.